KDR and breast carcinoma: A recent study has shown that VEGF-165 acts as an autocrine survival factor in NRP-1-positive breast carcinoma cells lacking VEGFR-2 and that this likely occurs through activation of the PI-3 kinase pathway (Bachelder et al, 2001).